Inventor · disambiguated record
Xue-Hai Liang
Also filed as: Liang xue-hai
11 granted patents·10 pending applications·22 citations·filing 2011–2025
86Inventor score
Top patents by PatentIndex Score
21 records- 0196US11149264B2Modified compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2021·Granted Oct 19, 2021·5 cites·29 claims
- 0291US11332733B2Modified compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2019·Granted May 17, 2022·4 cites·20 claims
- 0391US10822369B2Compounds and methods for the modulation of proteinsIONIS PHARMACEUTICALS INC·Filed 2015·Granted Nov 3, 2020·7 cites·15 claims
- 0490US11629348B2Linkage modified oligomeric compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2022·Granted Apr 18, 2023·2 cites·28 claims
- 0587US2025354135A1Modified Compounds and Uses ThereofIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0684US10370659B2Compounds and methods for increasing antisense activityIONIS PHARMACEUTICALS INC·Filed 2016·Granted Aug 6, 2019·3 cites·12 claims
- 0780US2025109164A1Compounds and methods for the modulation of proteinsIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0879US12234447B2Modified compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2022·Granted Feb 25, 2025·0 cites·21 claims
- 0979US2025368995A1Linkage Modified Oligomeric Compounds and Uses ThereofIONIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1075US9695475B2Competitive modulation of microRNAsIONIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 4, 2017·1 cites·15 claims
- 1170US12030910B2Compounds and methods for the modulation of proteinsIONIS PHARMACEUTICALS INC·Filed 2020·Granted Jul 9, 2024·0 cites·18 claims
- 1264US2018201930A1Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animalsIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1363US9845468B2Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animalsIONIS PHARMACEUTICALS INC·Filed 2016·Granted Dec 19, 2017·0 cites·17 claims
- 1462US9845467B2Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animalsIONIS PHARMACEUTICALS INC·Filed 2016·Granted Dec 19, 2017·0 cites·15 claims
- 1557US2014011860A1Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animalsLiang xue-hai·Filed 2011·Application pending·0 cites
- 1653US2018087107A1Competitive modulation of micrornasIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1751US2021380976A1Chirally enriched oligomeric compoundsIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1850US11492617B2Compositions and methods for modulation of protein aggregationIONIS PHARMACEUTICALS INC·Filed 2018·Granted Nov 8, 2022·0 cites·23 claims
- 1948US2021171945A1Methods of modulating antisense activityIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2047US2021355493A1Oligonucleotide mediated no-go decayIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2147US2020407717A1Methods of modulating antisense activityIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xue-Hai Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →